000 01322 a2200373 4500
005 20250511223318.0
264 0 _c19901105
008 199011s 0 0 eng d
022 _a0002-8703
024 7 _a10.1016/0002-8703(90)90194-3
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aThomas, M P
245 0 0 _aMyocardial infarct size reduction by the synergistic effect of hyperbaric oxygen and recombinant tissue plasminogen activator.
_h[electronic resource]
260 _bAmerican heart journal
_cOct 1990
300 _a791-800 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aCombined Modality Therapy
650 0 4 _aDogs
650 0 4 _aFemale
650 0 4 _aHyperbaric Oxygenation
650 0 4 _aMale
650 0 4 _aMyocardial Infarction
_xdrug therapy
650 0 4 _aMyocardium
_xenzymology
650 0 4 _aRecombinant Proteins
_xtherapeutic use
650 0 4 _aTissue Plasminogen Activator
_xtherapeutic use
700 1 _aBrown, L A
700 1 _aSponseller, D R
700 1 _aWilliamson, S E
700 1 _aDiaz, J A
700 1 _aGuyton, D P
773 0 _tAmerican heart journal
_gvol. 120
_gno. 4
_gp. 791-800
856 4 0 _uhttps://doi.org/10.1016/0002-8703(90)90194-3
_zAvailable from publisher's website
999 _c2127154
_d2127154